Chikungunya test vaccine shows promise

The trial drug is made with nanoparticles that resemble a West African strain of the virus, which causes high fever and arthralgia, said a study in The Lancet medical journal on Friday.

These virus-like particles (VLPs) are meant to mimic the immune-stimulating effects of the actual virus particles, but cannot cause disease as they contain no viral DNA.